Combination Therapy for Glaucoma Management

Mechanism of Action and Efficacy

• The American Academy of Ophthalmology recommends using dorzolamide-timolol eye drops and brimonidine eye drops together for glaucoma treatment, as they work through complementary mechanisms of action and have an additive effect in lowering intraocular pressure (IOP) in patients with glaucoma or ocular hypertension 1, 2

Evidence Supporting Combination Therapy

• Clinical guidelines from the American Academy of Ophthalmology support using multiple medication classes when a single agent fails to achieve target IOP, as combination therapy often provides additive effects in reducing IOP in patients with glaucoma 2

Administration Considerations

• The American Academy of Ophthalmology recommends waiting at least 5 minutes between administering different eye drops to prevent washout and ensure proper absorption in patients using multiple eye drops for glaucoma treatment 2
• Fixed combinations like dorzolamide-timolol can improve adherence by reducing the number of drops required, which is particularly beneficial when adding a third agent like brimonidine for patients with glaucoma 2, 3

Potential Side Effects and Monitoring

• Regular monitoring for local ocular and systemic side effects is essential, especially when using multiple medications like dorzolamide-timolol and brimonidine for glaucoma treatment, as recommended by the American Academy of Ophthalmology 2
• Patients should be assessed for medication adherence at each visit, as adherence tends to decrease with multiple medications, according to the American Academy of Ophthalmology 4, 3

Special Considerations

• In pregnancy, brimonidine has a Pregnancy Category B rating, while beta-blockers and carbonic anhydrase inhibitors have a Pregnancy Category C rating, as stated by the American Academy of Ophthalmology 3
• For patients with difficulty instilling multiple eye drops due to aging, comorbidities, or advancing glaucoma, additional instruction and written regimens may be necessary, as recommended by the American Academy of Ophthalmology 2, 3

Practical Approach

• Monitor IOP response at follow-up visits to ensure adequate pressure reduction in patients using dorzolamide-timolol and brimonidine for glaucoma treatment, as recommended by the American Academy of Ophthalmology 2
• Assess for side effects and adherence at each visit in patients using dorzolamide-timolol and brimonidine for glaucoma treatment, according to the American Academy of Ophthalmology 4, 2